
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 976 | 858 | 976 | 875 | 1177 | - |
Fund Return | -2.39% | -14.23% | -2.39% | -4.35% | 3.32% | - |
Place in category | 679 | 902 | 679 | 415 | 272 | - |
% in Category | 70 | 93 | 70 | 60 | 57 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Cleome Index USA Equities I USD Acu | 2.7B | 0.92 | 11.41 | - | ||
Cleome Index USA Eq C USD Acc | 2.7B | 23.07 | 6.84 | 11.23 | ||
Cleome Index USA Equities Z USD Acc | 2.7B | 24.19 | 7.88 | 12.43 | ||
Cleome Index USA Eq C USD Inc | 2.7B | 23.07 | 6.85 | - | ||
LU1864481467 | 1.57B | -2.39 | -4.36 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
World Healthscience Fund C2u | 390.41M | 7.12 | 3.81 | 5.84 | ||
World Healthscience Fund D2u | 1.23B | 7.46 | 5.90 | 7.98 | ||
World Healthscience Fund X2 USD | 43.76M | 7.63 | 6.94 | 9.06 | ||
World Healthscience Fund A2 | 6.65B | 7.33 | 5.11 | 7.17 | ||
World Healthscience Fund E2 | 2.17B | 7.24 | 4.59 | 6.64 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 7.00 | 805.23 | -2.50% | |
Merck&Co | US58933Y1055 | 5.35 | 87.11 | -2.95% | |
Roche Holding Participation | CH0012032048 | 4.79 | 292.40 | +0.65% | |
Regeneron Pharma | US75886F1075 | 4.36 | 617.00 | -2.72% | |
Thermo Fisher Scientific | US8835561023 | 4.33 | 482.97 | -2.94% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review